JoAnn V. Pinkerton, M.D.

Women are suffering in silence': UVa midlife health expert talks menopause

'Women are suffering in silence': UVa midlife health expert talks menopause Menopause has a stigma of “don’t ask, don’t tell” that causes more midlife health complications than necessary, according to JoAnn Pinkerton.

Quote today from one of our Bayer Oasis Study subjects who had severe hot flashes before the trial ""I want to stay on this the rest of my life". We are ACTIVELY Recruiting if you have bothersome hot flashes

The Bayer Oasis hot flash study is a phase 3 clinical trial being done across the country at multiple sites including UVA, designed to test a new non hormone ( non estrogen) medication called Elinzanetant in postmenopausal women with bothersome hot flashes. The medication works through the brain (neurokinen receptor antagonists) and we will be testing its effects on hot flashes, mood, and sleep. All participants will be randomized to receive either study drug or placebo for 3 months, then everyone receives the study drug for the next 3 months.

The PI is Dr. Jo Ann Pinkerton, division director of Midlife at UVA, with additional Midlife investigators of Carolyn Wilson, MIchelle Rindos, and Dana Redick.

Based on earlier studies, this medication is highly effective and we hope it will eventually offer a new nonestrogen effective treatment for hot flashes.

The study coordinator is Amanda Urban who can be reached at 434-409-3100. Or email us at [email protected] JoAnn

Thriving Over Forty & Beyond: Women's Midlife Health and Well-Being Thriving Over Forty & Beyond: Women's Midlife Health and Well-Being

Thriving Over Forty & Beyond:
Women's Midlife Health and Well-Being
Tuesday, November 1st
7 - 8 p.m. ET
This is an online event
Please join us for a special program to learn about UVA's commitment to women's lifelong health and well-being and the work of our Midlife Health Center, one of the only multidisciplinary centers in the country to specialize in caring for women over 40. From helping women navigate perimenopause, menopause, midlife sexuality, and gynecologic wellness, to addressing heart health, osteoporosis, and cancer prevention and treatment—UVA's world-class physicians, nurses, and researchers are leading the field of women's midlife health and offering a dedicated, holistic approach to women's physical and emotional needs during this key stage of life.

Our panel discussion will feature Dr. JoAnn Pinkerton (Col '76, Res '85), a nationally recognized expert in women's midlife health and division director of UVA's Midlife Health Center, and Dr. Paola Gehrig (Res '97), chair of the Department of Obstetrics and Gynecology and renowned specialist in gynecologic oncology. Renee Grisham will moderate the discussion, and an audience Q&A will follow.

Wendy Horton, CEO of UVA Health Medical Center, will offer brief opening remarks and share how UVA Health is championing women’s health at all stages of life.

The Zoom link will be e-mailed to all registrants on the morning of the event.

Register Now
https://www.eventbrite.com/e/thriving-over-forty-beyond-womens-midlife-health-and-well-being-registration-439113870407?j=2087963&sfmc_sub=28829505&l=11198_HTML&u=33640736&mid=100018202&jb=2

About our speakers:



JoAnn Pinkerton, MD is a professor of obstetrics and gynecology at UVA's School of Medicine where she serves as division director of UVA’s Midlife Health Center. A nationally recognized expert in women’s midlife health, Dr. Pinkerton is often featured in national media.



Paola Gehrig, MD is a gynecologic oncologist and chair of UVA’s Department of Obstetrics and Gynecology. She came to UVA in June 2022 after a long career at the University of North Carolina at Chapel Hill, where she was professor and chief of the Division of Gynecologic Oncology and the executive medical director of the North Carolina Women’s Hospital.



Renee Grisham is a notable local philanthropist, community volunteer, and longtime advocate of UVA’s Midlife Health Center and of Dr. JoAnn Pinkerton's work. Renee has led efforts to provide food, housing, education, healthcare, and environmental protections in places such as Virginia, Costa Rica, Haiti, and Peru.



Wendy Horton, PharmD, FACHE is the CEO of UVA Health Medical Center. UVA Health is a leading health system with a level 1 trauma center, a nationally recognized cancer center, children’s hospital and three community hospitals. Wendy joined UVA Health with extensive executive experience at nationally recognized academic medical centers.

This event is co-hosted by UVA Health and University Advancement’s Office of Engagement.

If you have any questions about the event, please contact [email protected].











University of Virginia
2420 Old Ivy Road
Charlottesville, VA, 22903
United States of America
Forward to a Friend

Update Your Address
Add New UVA Club Email Subscriptions
Unsubscribe

Thriving Over Forty & Beyond: Women's Midlife Health and Well-Being Thriving Over Forty & Beyond: Women's Midlife Health and Well-Being

Data on Cancer Risk From Hormone Therapy ‘Reassuring,’ UVA Menopause Experts Say | Connect (uvaconnect.com)
https://uvaconnect.com/data-on-cancer-risk-from-hormone-therapy-reassuring-uva-menopause-experts-say/

403 Forbidden

https://www.eurekalert.org/news-releases/962774

Data on cancer risk from hormone therapy 'reassuring,' menopause experts say A new scientific paper and other recent evidence offer important reassurances about the risk of breast cancer from hormone therapy to treat menopause symptoms, two University of Virginia School of Medicine menopause experts say.

Listen to the podcast with Courteney Stuart and Dr. JoAnn V. Pinkerton, M.D. on hormone and breast cancer

UVA’s Dr. JoAnn Pinkerton on Hormones & Risk of Breast Cancer | NewsRadio WINA Podcasts Photo: clipart.com, NewsRadio WINA UVA’s Dr. JoAnn Pinkerton on Hormones & Risk of Breast Cancer Posted on September 2, 2022 by sfederico Dr. JoAnn Pinkerton, director of the Midlife Health Center at the University of Virginia Medical Center, explains her new study that offers hopeful new...

https://www.nbc29.com/2022/09/01/uva-health-hormone-treatment-during-menopause-has-less-risks-than-previously-thought/

UVA Health: Hormone treatment during menopause has less risks than previously thought Research from UVA Health suggests that some of the information women use to make important decisions about menopause might be wrong.

Estrogen therapy at menopause in women with a hysterectomy does not increase the risk of invasive breast cancer. Longer term use 15-20 years or higher doses may increase. Women with a uterus need a progestogen which slightly increases the risk of breast cancer when combined with estrogen at menopause. Lower doses and use of progesterone rather than synthetic doses are safer. Transdermal, ie non oral, has less blood clot and stroke risk.
'

UVA Health: Hormone treatment during menopause has less risks than previously thought Research from UVA Health suggests that some of the information women use to make important decisions about menopause might be wrong.

Article is very appropriate for now

The New Midlife Crisis for Women Why (and How) it's hitting Generation X women - a crisis that impacts every aspect of their lives from relationships to career.